These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32334759)

  • 21. Revisiting pharmacy-based naloxone with pharmacists and naloxone consumers in 2 states: 2017 perspectives and evolving approaches.
    Green TC; Donovan E; Klug B; Case P; Baird J; Burstein D; Tapper A; Walley AY; Bratberg J
    J Am Pharm Assoc (2003); 2020; 60(5):740-749. PubMed ID: 32334964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states.
    Green TC; Case P; Fiske H; Baird J; Cabral S; Burstein D; Schwartz V; Potter N; Walley AY; Bratberg J
    J Am Pharm Assoc (2003); 2017; 57(2S):S19-S27.e4. PubMed ID: 28214219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities.
    Lai Joyce Chun K; Olsen A; Taing MW; Clavarino A; Hollingworth S; Dwyer R; Middleton M; Nielsen S
    Res Social Adm Pharm; 2019 Aug; 15(8):1014-1020. PubMed ID: 30926251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing pharmacy student experience with, knowledge of and attitudes towards harm reduction: illuminating barriers to pharmacist-led harm reduction.
    Mahon LR; Hawthorne AN; Lee J; Blue H; Palombi L
    Harm Reduct J; 2018 Nov; 15(1):57. PubMed ID: 30445958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of a mental health course elective on student pharmacist attitudes.
    Robinson JD; Maslo TE; McKeirnan KC; Kim AP; Brand-Eubanks DC
    Curr Pharm Teach Learn; 2020 Jul; 12(7):885-892. PubMed ID: 32540052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining simulated academic detailing with naloxone training to prepare student pharmacists for opioid risk mitigation strategies.
    Kavanaugh R; Yerks M; Feldman R; Stanton M
    Curr Pharm Teach Learn; 2021 Dec; 13(12):1679-1682. PubMed ID: 34895678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naloxone and the Inner City Youth Experience (NICYE): a community-based participatory research study examining young people's perceptions of the BC take home naloxone program.
    Mitchell K; Durante SE; Pellatt K; Richardson CG; Mathias S; Buxton JA
    Harm Reduct J; 2017 Jun; 14(1):34. PubMed ID: 28592287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the Impact of Participating as Pharmacy Camp Counselors on Student Pharmacists' Professional Identity.
    Ford CR; Kleppinger EL; Helms K
    Am J Pharm Educ; 2020 Jan; 84(1):7128. PubMed ID: 32292192
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence.
    Raisch DW; Fudala PJ; Saxon AJ; Walsh R; Casadonte P; Ling W; Johnson BA; Malkerneker U; Ordorica P; Williford WO; Sather MR
    J Am Pharm Assoc (2003); 2005; 45(1):23-32. PubMed ID: 15730114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding naloxone education in the doctor of pharmacy curriculum.
    Musco S; Kicklighter J; Arnett A
    Curr Pharm Teach Learn; 2022 Mar; 14(3):310-317. PubMed ID: 35307090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of a depression counseling intervention on student pharmacists' confidence and comfortability: A pilot study.
    Dean TA; Bamgbade BA; Barner JC; Rush SK; Burdine KM
    Curr Pharm Teach Learn; 2020 Apr; 12(4):410-417. PubMed ID: 32334756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Student Perspectives Regarding Specialty Pharmacy Within Doctor of Pharmacy Curricula.
    Fava JP; Zofchak KM; Jedinak TJ; Erickson SR
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1255-1259. PubMed ID: 31663463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.
    Stopka TJ; Donahue A; Hutcheson M; Green TC
    J Am Pharm Assoc (2003); 2017; 57(2S):S34-S44. PubMed ID: 28189540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of a Film on Student Pharmacists' Views on Quality of Life and Aging.
    Miller SW; Lundquist LM
    Am J Pharm Educ; 2020 Apr; 84(4):7628. PubMed ID: 32431311
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of pharmacist counseling to enhance the accessibility of naloxone nasal spray to patients in a community pharmacy setting.
    Napoli K; Grant M; Remines J; Nadpara P; Goode JR
    J Am Pharm Assoc (2003); 2021; 61(4S):S127-S134. PubMed ID: 33441280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Student Pharmacists' Perspectives on Service-Learning Experiences in Free Clinics.
    Ko J; Connor S; Jonkman L; Abraham O
    Am J Pharm Educ; 2019 Nov; 83(9):7379. PubMed ID: 31871359
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of a pharmacist-led naloxone coprescribing program in primary care.
    Cariveau D; Fay AE; Baker D; Fagan EB; Wilson CG
    J Am Pharm Assoc (2003); 2019; 59(6):867-871. PubMed ID: 31466899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of student pharmacist-led naloxone academic detailing at community pharmacies in Texas.
    Evoy KE; Groff L; Hill LG; Godinez W; Gandhi R; Reveles KR
    J Am Pharm Assoc (2003); 2020; 60(1):81-86. PubMed ID: 31669417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal.
    Nielsen S; Menon N; Larney S; Farrell M; Degenhardt L
    Addiction; 2016 Dec; 111(12):2177-2186. PubMed ID: 27367125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reviewing state-mandated training requirements for naloxone-dispensing pharmacists.
    Roberts AW; Carpenter DM; Smith A; Look KA
    Res Social Adm Pharm; 2019 Feb; 15(2):222-225. PubMed ID: 29650444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.